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CASE PRESENTATION
A 49-year-old Hispanic female with a past medical history
notable for systemic lupus erythematosus (SLE) and
biopsy proven lupus nephritis, hypertension, and peptic
ulcer disease was referred for evaluation of hematuria. The
patient also reported recent h/o arthralgias, some
worsening of her existing malar and discoid rashes, and
intermittent fevers. She denied any history of gross
hematuria, dyspnea, chest pain, abdominal pain, fatigue,
oral ulcers, Raynaud’s phenomenon, or edema. The
patient was seen by her nephrologist and found to have
4þ protein and 2þ blood on urinalysis with urine
sediment revealing moderate dysmorphic red cells and no
casts. Her first kidney biopsy revealed diffuse proliferative
lupus nephritis World Health Organization class IV. At this
time, the patient had undergone treatment with monthly
cyclophosphamide infusions along with steroids for 6
months. Her renal function revealed a creatinine clearance
of 75 ml/min. Urinalysis revealed only few red blood cells
with no casts, with resolution of her proteinuria. The
frequency of cyclophosphamide pulses was decreased to
every 3 months for the next 12 months, which was the
dose at the patient’s current presentation. Her medica-
tions included cyclophosphamide 0.85 g/m2 every 3
months, prednisone 15 mg p.o. q.d., plaquenil 200 mg p.o.
b.i.d., lisinopril 40 mg p.o. q.d., nifedipine XL 60 mg p.o.
q.d., and calcium/multivitamin supplements. Her family
history was negative for hematuria, proteinuria, or any
other known renal disease. The patient was originally from
El Salvador and had been in the United States for 11 years.
She denied tobacco consumption and drank alcohol
occasionally. Physical examination revealed a middle-aged
female with a Cushingoid appearance. Her weight was
stable at 162 lbs. Her blood pressure was 130/70 mmHg;
she was afebrile. Skin examination revealed increased
erythematous lesions in a malar distribution, along with a
circular, erythematous, maculopapular rash throughout
the proximal regions of her upper extremities and the
upper front and back of her thorax in a shawl type
of pattern. Musculoskeletal examination revealed no
evidence for active synovitis. Lungs were clear to
auscultation and her abdomen was benign. Her heart
examination revealed a regular rate and rhythm with an
I/VI systolic ejection murmur at the left sternal border,
with no rubs or gallop. Extremities revealed trace pedal
edema bilaterally. Laboratory values revealed a blood urea
nitrogen and creatinine of 23 and 0.7 mg/dl, respectively;
white blood cells 5.87; hemoglobin 11.0 g/dl; hematocrit
33.9; platelets 298,000; electronic spin resonance 81;
double-stranded DNA 475 IU (Normal – 0–25 IU); C3
52(Normal – 90–180 mg/dl); C4 16 (Normal – 10-40 mg/dl),
and CH50 of 62 (Normal – 150–250 U/ml). Twenty-four
hours protein collection revealed 1.075 g of proteinuria.
Owing to persistent activity of her sediment as well as
abnormal serologic tests (Table 1), the frequency of the
cyclophosphamide infusions were increased from every
3 months to every month, and a repeat biopsy was
performed in December of 1998.
RENAL BIOPSY FINDINGS
Renal biopsy in December 1998 (Figure 1a) revealed 21
glomeruli, five of these were obsolescent, three showed
fibrous crescents, and the remaining glomeruli showed
minimal signs of activity with rare karyorrhexis, and
moderate increase and proliferation of mononuclear cells
within the mesangium and no significant infiltration of the
tuft by neutrophils or mononuclear cells. Wire loops or
microthrombi were not seen. Double contours were observed
in the glomerular basement membrane (GBM) on periodic
acid-Shiff stain. Tubular atrophy and interstitial fibrosis
involving 40% of the sample was observed on the trichrome
stains. Arteries revealed moderate sclerosis of the walls and
focal hyaline accumulation in the subintima. Thus, the
activity index (AI) was 4/24 and the chronicity index (CI)
was 6/12. Immunofluorescence microscopy revealed granular
deposits of immunoglobulin (Ig)G (4þ ), C3 and C1q (3þ ),
and IgA (1þ ) along the peripheral capillary wall and in
the mesangial area. On electron microscopy (EM) (Figure 1b)
five glomeruli were examined. Few finely granular electron-
dense deposits were observed in the subendothelial
region and in the mesangium. The GBM was thin, and
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measurements at 142 sites were carried out using the
orthogonal intercept method, and mean GBM thickness
was observed to be 209 nm. This value is below the lower
normal limit of 264 nm, as described by Tiebosch et al.1
CLINICAL DIAGNOSIS
Lupus nephritis with thin basement membrane (class IV with
mild active and chronic lesions).
CLINICAL FOLLOW-UP
The patient’s previous renal biopsy carried out in January 1997
was re-reviewed and revealed class IV lupus nephritis with
membranoproliferative lesions (class IV), activity index 11/24,
and chronicity index 2/12 (Figure 2a). On EM examination, in
addition to extensive mesangial and subendothelial electron-
dense deposits, focal thin basement membranes were observed
(Figure 2b). Morphometric measurements carried out at 130
sites by the orthogonal intercept method revealed an average
GBM thickness of 239 nm. Thus, the second renal biopsy in this
patient with lupus nephritis revealed the coexistent presence of
thin glomerular basement membrane abnormalities (TBMA).
Re-review of the first biopsy (from January 1997) carried out
again (earlier reported by another pathologist) revealed on
morphometric measurements the presence of TBMA that had
hitherto not been recognized.
From a clinical perspective, the patient’s blood pressure
remained under suboptimal control and valsartan was added
to her regimen. Hypertension was also treated with hydro-
chlorothiazide 25 mg p.o. q.d., which was later increased to
50 mg p.o. q.d. Her cyclophosphamide was then subsequently
decreased to q 3 monthly infusions, which was continued for
1 year, after which it was stopped in the setting of stable renal
function. She continued to have mild hematuria probably
stemming from her thin basement membrane disease in the
absence of proteinuria and serologic evidence of active lupus
nephritis.
Table 1 | Laboratory results
Date 12/96 1/97 10/98 11/98 3/99 10/99 10/00 11/02 01/03 10/04 01/05
Serum/blood
BUN (mmol/l) 28 48 27 23 32 26 — — — — —
Cr (mg/dl) 1.3 1.4 0.6 0.7 0.8 0.9 — 0.7 0.8 0.7 0.8
C3 — — 29 52 55 27 104 — 104 124 121
C4 — — o10 16 — o10 10 — 20 30 25
CH50 o20 o20 41 62 — 47 135 — 173 225 164
Anti-dsDNA 108.3 — 334 475 307 66 48 24 32 8 10
ANA 1:640 — — — — — — 1/80 1/20 — Trace
ANA pattern Speck — — — — — — Speck Speck — Speck
ESR 86 30 63 81 — — — 19 14 19 6
Urinalysis
Blood 3+ 3+ 3+ 1+ 2+ 2+ — 1+ 1+ 1+ 1+
Protein 3+ 1+ 2+ 2+ 1+ 2+ — Neg Trace Neg Neg
Urine protein
Malb/Cr (mg/g) — — — — — — — — — 10.7 24.4
24 h protein (g) 0.670 0.225 — 1.075 4.605 — 0.610 0.139 0.132 — —





Figure 1 | Review of second bx. (a) Two glomeruli with mild
cellularity and a segmental fibrocellular crescent (class IV-G lupus
nephritis active and chronic lesion). (b) Electron micrograph showing
( ) subendothelial electron dense deposits and ( ) TBMA.
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DISCUSSION
This is the first report to our knowledge of coexisting TBMA
and lupus nephritis. In our case, only after a repeat renal
biopsy was the hematuria attributed to the concomitant
presence of TBMA. Our case emphasizes the importance of
suspecting the coincidental presence of TBMA in patients
with lupus nephritis who have persistent microscopic
hematuria that is clinically discordant with the clinical and
laboratory assessment of disease activity. Furthermore, the
association of TBMA with lupus nephritis emphasizes the
importance of EM evaluation in these patients.
The presence of TBMA in association with lupus nephritis
rekindles an existing debate. Is the occurrence of lupus
nephritis coincidental with the presence of TBMA or does the
presence of lupus nephritis predispose the patient to TBMA?
The association of TBMA with several other glomerular
entities raises the possibility that subtle perturbations in
glomerular physiology could have resulted in abnormalities
in basement membrane synthesis.2,3 Coleman and Stirling4 as
well as Fujinaga et al.5 noted GBM thinning in minimal
change disease. Other investigators have described TBMA
along with IgA nephropathy,6,7 focal segmental glomerulo-
sclerosis,8 diabetic nephropathy,9 and rarely membranous
nephropathy.10 Baranowska-Daca et al.11 reported one
patient with TBMA in the setting of systemic lupus
erythematosus (SLE) as a cause of non-lupus renal disease.
Cosio et al.2 and Sue et al.8 demonstrated that 73% and 76%
of native kidney biopsy specimens with TBMA had an
associated glomerular pathology. Norby and Cosio3 have
postulated three explanations for the association of TBMA
with other GN. They suggest that the association of minimal
change disease with TBMA may be artifactual, although
Marquez et al.12 postulate the epithelial cell dysfunction to be
a cause of GBM thinning in these cases with minimal change
disease. Considering the high prevalence of TBMA in the
general population (7% in the general population), the
association with diabetes and membranous nephropathy is
probably co-incidental.13 Association of IgA nephropathy
and TBMA is known and is higher than expected for the
population.2 Linossier et al.14 have demonstrated that there
are differences in the glycosylation of serum IgA1 depending
on the GBM thickness, normal versus TBMA, in patients
with IgA nephropathy.13 Similarly, Sue et al.8 have noted that
the most common additional lesion noted with TBMA was
focal segmental glomerulosclerosis. Indeed, Hill and Good-
loe15 have reported GBM lesions mimicking Alport syn-
drome or TBMA in a wide variety of nephropathies. They
claim that the GBM alterations that they observed could be
secondary to membrane damage and subsequent attempts at
repair. It is, however, important to note that in patients with
TBMA and other glomerulopathies, TBMA will be under-
diagnosed if EM is not performed.
Patients with TBMA who present with persistent micro-
scopic hematuria, often associated with hypertension and
proteinuria in late middle age, have been labeled as thin
basement membrane disease. The genetic basis of thin
basement membrane disease has been elucidated and involves
polymorphisms in the gene coding for alpha4 or alpha3 type
IV collagen.16 TBMA has an autosomal-dominant inheri-
tance in two-thirds of patients affected. Rarely, TBMA has
been proved to be a carrier state for the autosomal-recessive
or X-linked Alport syndrome.17–20 Recent studies have shown
that clinical and histological phenotypes of TBMA to be
diverse, with the vast majority of subjects with TBMA having
familial microscopic hematuria, frequently associated with
hypertension and proteinuria in late/middle age.8,21,22 Several
published reports of TBMA with renal insufficiency indicate
that TBMA is not as benign as regarded previously.22,23
Nieuwhof et al.23 attribute hypertension and progression





Figure 2 | Review of first bx. (a) Active class IV lupus nephritis with
marked cellularity of endothelial and mesangial cells and (b)
infiltration with occasional polymorphonuclear cells with obliteration
of glomerular capillaries. ( ) Subendothelial deposits and ( ) TBMA.
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the presence of premature glomerular obsolescence (focal
or global).
There are no universally accepted histopathologic criteria
for the diagnosis of TBMA. TBMA is often defined by GBM
thickness 2 s.d’s. below the mean. Optimally, the mean and
s.d. is defined individually by each EM facility for its patient
population. By definition, approximately 3% of patients meet
the criteria for TBMA, although this terminology is not
typically applied unless the patient has evidence of micro-
hematuria. As a result, 3% of patients with lupus nephritis,
focal segmental glomerulosclerosis, or any glomerular lesion
will meet EM criteria for TBMA. Yet, there are no reported
cases of lupus nephritis concomitantly present along with
TBMA. Some suggest, among children, the definition of thin
basement membrane to be from o200 to o250 nm,
depending on age, and in adults from o200 to o264 nm
(as suggested by Tiebosch et al.1). The World Health
Organization also defines TBMA thickness to be
o264 nm.24 Another issue of importance in the interpreta-
tion of the pathology of patients with glomerulopathy and
basement membrane thinning relates to the extent or
magnitude of the thinning in the basement membrane.
Savige et al.25 propose that in TBMA the GBM is thinned in
the majority of capillary loops, and at least 50% of capillary
loops are thinned in individual capillary loops . However,
Norby and Cosio3 suggest that in their experience and also
historically, the first reported family of TBMA had only focal
thinning of the GBM. Our own approach, and the one used
in the current case report, is to diagnose TBMA using a
sampling approach. Over 100 measurements are performed
on capillary loops from more than one glomerulus to obtain
a mean GBM thickness. A mean GBM thickness o264 nm
meets the criteria for TBMA. Of course, it is impractical to
routinely perform hundreds of measurements on every EM
specimen received, but it is important to routinely scrutinize
the entire grid and especially examine carefully more than
one glomerulus, particularly when a coexisting lesion
dominates the picture. If focal areas of thinning are present,
morphometric measurements to confirm the diagnosis are
then indicated. Lupus nephritis class IV with an activity
index of 4 could also cause microhematuria. Class IV lupus
nephritis with low activity, in the absence of thin basement
membrane disease, is certainly a reasonable explanation for
chronic microhematuria. Baranowska-Daca et al.11 have
reported non-lupus nephritides leading to a clinical pre-
sentation mimicking lupus nephritis (microhematuria and/
proteinuria) in patients with SLE and these included one
case each of TBMA, amyloidosis, and acute tubulointerstitial
disease, two each of IgM nephropathy and hypertensive
nephropathy and six cases with focal segmental glomerulone-
phritis. Hertig et al.26 and, more recently, Kraft et al.27
have demonstrated glomerular podocytopathy in patients
with lupus nephritis and a nephrotic syndrome. The
latter authors, however, consider it as a manifestation of
SLE rather than the minimal change disease in a case
with SLE.
It is noteworthy that the GBM thickness decreased by
12.5% between biopsies from 239 to 209 nm. There is no
conclusive explanation for this observation. One hypothesis
to explain this could be a sampling error; another possibility
would be remodeling of the lamina densa in the setting of
active glomerular inflammation, resulting in proteolytic
degradation of this structure.
This case illustrates the importance of not assuming that
hematuria in a patient with lupus nephritis always reflects
lupus disease activity. Reviewing and re-reviewing the renal
biopsy with the nephropathologist is a valuable exercise. As
well, scrutinizing the renal biopsy for alternative explana-
tions, such as thinning of the GBM, when the clinical
scenario is discordant with the histopathology is important.
Finally, this case underscores the importance of EM in the
management of patients with lupus nephritis.
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